• Axsome Therapeutics COO Mark L. Jacobson exercised stock options for 10,000 common shares at $12.95 on Sept. 3, 2026.
• He sold 10,000 common shares the same day at a weighted average price of $208.65.
• Directly held common stock position fell to 0 shares following the transactions.
• Directly held stock options totaled 104,954 following the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-382277), on September 03, 2026, and is solely responsible for the information contained therein.